Indegene Limited

Indegene Limited wins 2024 award in HealthTech

Indegene Limited, a digital-first, life sciences commercialization company, has won the Deloitte Technology Fast 50 India 2024 Award in HealthTech. The Company celebrates and honours the fastest growing technology-enabled business based on their average revenue growth over a three-year period. About Indegene-http://t www.indegene.com Indegene Limited founded in 1998, is a digital-first, life sciences commercialization company….

Read More
Indegene Limited

Suven Pharmaceuticals to invest USD 64.4 million in “NJ Bio”

Suven Pharmaceuticals, a technology-leading CDMO specializing in complex and innovate drug modalities, has announced the acquisition of 56% equity stake in “NJ Bio”. The Company has acquired 56% equity stake in ‘NJ Bio’ at a USD 100 million pre-money valuation, investing USD 64.4 million, including USD 15 million for growth initiatives. Suven Pharmaceuticals will acquire…

Read More